Practicing in a diverse area, Joanna Rhodes, MD, MSCE, notes differences in the disease biology of chronic lymphocytic leukemia (CLL) in non-White patients, particularly in younger Black patients, who often have more aggressive disease but are underrepresented in clinical trials.
Dr Rhodes emphasizes the importance of enrolling non-White patients in clinical trials and ongoing research to understand potential differences in disease biology and optimize treatment for these patients.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Racial Disparities in CLL: Underrepresentation in Clinical Trials - Medscape - May 30, 2023.
Comments